Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries

NCT01961167 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT01961167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01961167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the GORE® VIABAHN® BALLOON EXPANDABLE ENDOPROSTHESIS (VIABAHN BX) for the Treatment of Occlusive Disease in the Common and External Iliac Arteries
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
December 14, 2017
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common iliac artery occlusive disease, external iliac artery occlusive disease, peripheral arterial disease